Lynda Charters Enoch started her early “eye life” at the Schepens Eye Research Institute, Boston, which ultimately culminated in her current position as an Editor of Ophthalmology Times.
ILM peeling prevents development of ERMs
Only 2% of patients with internal limiting membrane peeling developed an epiretinal membrane compared with 46% with no peeling.
Read More
FAF sheds light on patterns related to disease chronicity in CSC
Fundus autofluorescence is a helpful tool for diagnosing central serous choroidopathy and planning treatment.
Anti-VEGF therapy may prevent/delay radiation maculopathy in choroidal melanoma
Immediate administration after radiation therapy is key.
Subretinal gene therapy safe with visual benefit
This study provided clinical proof of concept for viral vector-mediated gene supplementation therapy of inherited day blindness caused by pathogenic variants in the cone photoreceptor-specific gene CNGA3.
How DME patients may fare differently in ‘real world’ versus trials
Screening DR + tele-ophthalmology AI: Less expensive than human assessment
Determining risk of ocular damage from chronic intravitreal injections
PACK-CXL researchers continue to clear hurdles of topical drugs
Technology 'perfect' for pediatric neuro-ophthalmology diagnoses
Researchers find low risk of COVID-19 transmission in tears
What retinal specialists should know about their pregnant patients
How autonomous diagnostics for DR gave a ‘jump-start’ to AI in ophthalmology
AMD awareness: Close focus on preserving vision
Stem cell transplantation: Restoring vision in AMD may be possible
Connect the dots: Diagnosing, managing multifocal choroiditides
Retina risk app tool empowers diabetic patients worldwide
Obesity + diabetic retinopathy: Korean study explores inverse association
DNA analysis: Unraveling role of genetics in DR pathogenesis
Lipid-lowering drugs, lower DR risk may go hand in hand
Laser treatment for DME: Still a place at the table
Determining DR progression: Much work still needs to be done
Image-reading accuracy Increases with deep-learning DR algorithms
Laser’s place in diabetic retinopathy: Choosing the right scenario
Successful PDR outcomes driven by strict adherence to follow-up
Adalimumab efficacious for uveitis regardless of disease duration
Quiescence, steroid-free quiescence achieved in VISUAL III trial
Managing uveitic macular edema
Intravitreal triamcinolone acetonide, dexamethasone implant superior for regional treatment of disorder
Cataract surgery in patients with diabetes: No time like the present
When and how to treat myopic traction maculopathy
New name for an old problem
Steroid therapy for DME: Yes or maybe?